A study to learn about the study medicine called PF-08046032 in people with advanced cancers.
C5911001 - SGN-CD25V
Phase 1 other active
Quick answer
A study to learn about the study medicine called PF-08046032 in people with advanced cancers. for Advanced lymphomas (classic Hodgkin lymphoma [cHL], peripheral T cell lymphoma [PTCL], and diffuse large B cell lymphoma [DLBCL]), Solid tumors (eg, NSCLC, HNSCC, and melanoma) is a Phase 1 program (other) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Advanced lymphomas (classic Hodgkin lymphoma [cHL], peripheral T cell lymphoma [PTCL], and diffuse large B cell lymphoma [DLBCL]), Solid tumors (eg, NSCLC, HNSCC, and melanoma)
- Phase
- Phase 1
- Modality
- other
- Status
- active